About Emeritus Pharma Private Limited
Data last updated: 08 May 2026
Emeritus Pharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India, recognised as a startup by DPIIT. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 26 December 2017, the company has been in operation for over 9 years.
Registered with ROC Ahmedabad under CIN U51909GJ2017PTC100254.
Capital: an authorised share capital of ₹10.5 Lakh and a paid-up capital of ₹1.42 Lakh. It is led by directors including Ankur Agarwal and Parasharan Narasimha Chari.
Last AGM: 25 September 2025. Financial statements filed for year ended 31 March 2025. Office: A – 202 Heritage Skyz B/H Shivalik Prahalad Nagar, Ahmedabad, Gujarat, India – 380015.
As per the financials filed for FY 2025, the company reported a revenue of ₹43.71 Cr, a growth of 6% compared to the previous year.
The company has a workforce of approximately 1 employees as per the latest available data. Its group structure includes 2 subsidiaries.
The company is associated with 1 brand - Medkart.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website emeritus.co.in.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media**************
-
Registered AddressA – 202 Heritage Skyz B/H Shivalik Prahalad Nagar, Ahmedabad, Gujarat, India – 380015
-
IndustryPharma, Drug Formulation & Development
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Emeritus Pharma Private Limited
Emeritus Pharma Private Limited operates one associated brand: Medkart. These brands represent Emeritus Pharma Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Online platform for comparison of prices and purchase of medicines | medkart.in |
Competitors & Alternatives of Emeritus Pharma Private Limited
Brands and companies operating in the same space as Emeritus Pharma Private Limited include PharmLane, Medlr, Pharmacy Checker Online and 2 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
PharmLane
|
An online platform that helps users locate local pharmacies and compare medication prices. | Ahmedabad, India, India | 2018 |
Medlr
|
Operates a digital hub for comparing pharmacy prices. | Chandigarh, India, India | 2022 |
Pharmacy Checker Online
|
Pharmacy Checker Online offers drug price comparisons and verification services for online pharmacies. | Navi Mumbai, India, India | 2003 |
Dava Ninja
|
Offers an online platform to compare medicine prices and delivery times from pharmacies. | Mumbai, India, India | 2022 |
Meedgo
|
Offers a digital platform for price discovery and competitive pricing on medications. | Jhansi, India, India | 2022 |
Business Activity of Emeritus Pharma Private Limited
Emeritus Pharma Private Limited is engaged in the principal business activity of trade, with detailed activities including retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | ********* |
Auditor Details of Emeritus Pharma Private Limited
Emeritus Pharma Private Limited is audited by M. S. CHHAJED & CO. for the financial year 2024. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M. S. CHHAJED & CO. | blur-value | blur-value | blur-value |
Board of Directors of Emeritus Pharma Private Limited
Emeritus Pharma Private Limited is currently managed by 3 directors, with 3 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Ankur Agarwal
Also directs:
Mittal Nirman Llp, Kheria Autocomp Limited, Trakdem Solutions Private Limited and 1 more
|
Director | 21 Sep 2019 | 6 Years 9 Months | Current |
| Parasharan Narasimha Chari | Director | 29 May 2021 | 5 Years 1 Months | Current |
|
Jyoti Narang
Also directs:
Heidelbergcement India Limited., Brigade Hotel Ventures Limited, Nab Global Innovation Centre India Private Limited and 4 more
|
Nominee Director | 19 May 2022 | 4 Years 1 Months | Current |
Financials of Emeritus Pharma Private Limited FY 2025 filings available
Emeritus Pharma Private Limited reported revenue of ₹43.71 Cr (up 6% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Emeritus Pharma Private Limited
As of FY 2025, Emeritus Pharma Private Limited's shareholding pattern shows 96.03% by promoters, 3.77% by public shareholders. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Group Structure of Emeritus Pharma Private Limited
Emeritus Pharma Private Limited has 2 subsidiary companies. This group structure data is as of FY 2025. The corporate group structure reflects Emeritus Pharma Private Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Trakdem Solutions Private Limited | U51397GJ2021PTC122737 |
**.**%
|
| Medkart Pharmacy Private Limited | U74999GJ2019PTC107176 |
**.**%
|
Showing major subsidiaries. Total: 2.
Charges & Borrowings Emeritus Pharma Private Limited
Emeritus Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Emeritus Pharma Private Limited
Emeritus Pharma Private Limited has a workforce of 1 employees as of Oct 10, 2025.
Employee Count & EPFO Data of Emeritus Pharma Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Emeritus Pharma Private Limited
GSTIN & GST Filing Data of Emeritus Pharma Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Emeritus Pharma Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Emeritus Pharma Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Emeritus Pharma Private Limited
MSME Payment Delays by Emeritus Pharma Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Emeritus Pharma Private Limited
Subsidiaries & Group Companies of Emeritus Pharma Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Emeritus Pharma Private Limited with ownership details.
MCA Filings & Documents of Emeritus Pharma Private Limited
MCA Filings & Documents of Emeritus Pharma Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Emeritus Pharma Private Limited
Frequently Asked Questions about Emeritus Pharma Private Limited
Emeritus Pharma Private Limited is an active private limited company in the pharma sector based in Ahmedabad, Gujarat, India. It was incorporated on 26 December 2017 (9+ years old) and is registered under CIN U51909GJ2017PTC100254. The company has 1 employees.
Emeritus Pharma Private Limited reported revenue of ₹43.71 Cr for FY 2025 (up 6.00% YoY).
The current directors of Emeritus Pharma Private Limited are:
The primary industry of Emeritus Pharma Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.
Yes, Emeritus Pharma Private Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Emeritus Pharma Private Limited can be reached at the registered office: A – 202 Heritage Skyz BH Shivalik Prahalad Nagar, Ahmedabad, Gujarat, India – 380015, or through the website emeritus.co.in.